MedTrace Logo

TruGraf and TRAC In Pediatrics Study

NCT05335538 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2022-04-19

No results posted yet for this study

Summary

This is a pilot 3 center prospective study of pediatric renal kidney recipients undergoing protocol biopsies examining the performance of the TruGraf gene expression test in children and adolescents.

Conditions

  • Kidney Transplant Rejection

Interventions

DIAGNOSTIC_TEST

Patients monitored with TruGraf and TRAC testing

This is an observational study there are no protocol mandated interventions. TruGraf and TRAC results will be utilized in conjunction with standard of care assessments to determine patient management.

Sponsors & Collaborators

  • University of Alabama at Birmingham

    collaborator OTHER

  • University of British Columbia

    collaborator OTHER

  • University of California, Los Angeles

    collaborator OTHER

  • Transplant Genomics, Inc.

    lead INDUSTRY

Principal Investigators

  • Patty West-Thielke, PharmD · Transplant Genomics

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-30
Primary Completion
2022-12-30
Completion
2023-03-01

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05335538 on ClinicalTrials.gov